We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

0HI3 Arrowhead Pharmaceuticals Inc

0.00 (0.00%)
28 Feb 2024 - Closed
Delayed by 15 minutes

Arrowhead Pharmaceuticals Financial Summary

The current 0HI3 market cap is 1.21B. The company's latest EPS is USD -1.6568 and P/E is -20.52.

Year End 30 September 2023 20192020202120222023
Total Revenue 168.8M87.99M138.29M243.23M240.74M
Operating Income 61.19M-93.16M-149.04M-178.51M-205M
Net Income 67.98M-84.55M-140.85M-176.06M-205.28M
Year End 30 September 2023 20192020202120222023
Total Assets 349.85M522.5M710.15M691.94M765.55M
Total Liabilities 105.81M60.73M301.33M273.6M478.39M
Total Equity 244.04M461.78M408.82M418.34M287.16M

Cash Flow

Year End 30 September 2023 20192020202120222023
Operating 173.04M-95.39M171.22M-136.13M-153.89M
Investing -47.75M-240.78M-141.68M-5.42M-96.16M
Financing 66.38M257.95M11.31M65.19M253.05M
Market Cap 1.21B
Price to Earnings Ratio -20.52
Price to Sales Ratio 17.5
Price to Cash Ratio 40.9
Price to Book Ratio 14.67
Dividend Yield -

Share Statistics

Shares Outstanding 123.9M
Average Volume (1 week) 3.44k
Average Volume (1 Month) 1.32k
52 Week Change 0.00%
52 Week High 9.77
52 Week Low 9.77
Spread (Intraday) 0 (0%)

Company Info

Company Name Arrowhead Pharmaceuticals Inc
Address 2140 south dupont highway
camden, delaware 19934
Industry coml physical, biologcl resh (8731)

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |